A C. elegans model of C9orf72-associated ALS/FTD uncovers a conserved role for eIF2D in RAN translation

Sonobe, Yoshifumi; Aburas, Jihad; Krishnan, Gopinath; Fleming, Andrew C.; Ghadge, Ghanashyam; Islam, Priota; Warren, Eleanor C.; Gu, Yuanzheng; Kankel, Mark W.; Brown, André E. X.; Kiskinis, Evangelos; Gendron, Tania F.; Gao, Fen-Biao; Roos, Raymond P.; Kratsios, Paschalis

doi:10.1038/s41467-021-26303-x

Download PDF

Article
Open access
Published: 15 October 2021

A C. elegans model of C9orf72-associated ALS/FTD uncovers a conserved role for eIF2D in RAN translation

Nature Communications volume 12, Article number: 6025 (2021) Cite this article

5910 Accesses
24 Citations
30 Altmetric
Metrics details

Subjects

Abstract

A hexanucleotide repeat expansion GGGGCC in the non-coding region of C9orf72 is the most common cause of inherited amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Toxic dipeptide repeats (DPRs) are synthesized from GGGGCC via repeat-associated non-AUG (RAN) translation. Here, we develop C. elegans models that express, either ubiquitously or exclusively in neurons, 75 GGGGCC repeats flanked by intronic C9orf72 sequence. The worms generate DPRs (poly-glycine-alanine [poly-GA], poly-glycine-proline [poly-GP]) and poly-glycine-arginine [poly-GR]), display neurodegeneration, and exhibit locomotor and lifespan defects. Mutation of a non-canonical translation-initiating codon (CUG) upstream of the repeats selectively reduces poly-GA steady-state levels and ameliorates disease, suggesting poly-GA is pathogenic. Importantly, loss-of-function mutations in the eukaryotic translation initiation factor 2D (eif-2D/eIF2D) reduce poly-GA and poly-GP levels, and increase lifespan in both C. elegans models. Our in vitro studies in mammalian cells yield similar results. Here, we show a conserved role for eif-2D/eIF2D in DPR expression.

Messenger RNA transport on lysosomal vesicles maintains axonal mitochondrial homeostasis and prevents axonal degeneration

Article Open access 10 April 2024

APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia

Article Open access 13 March 2024

Integrated proteomics reveals autophagy landscape and an autophagy receptor controlling PKA-RI complex homeostasis in neurons

Article Open access 10 April 2024

Introduction

The GGGGCC (G4C2) hexanucleotide repeat expansion in the non-coding region of C9orf72 is the most common monogenic cause of inherited amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)^1,2, and also causes up to 10% of what appears to be sporadic ALS. The G4C2 repeat expands in patients to hundreds or thousands of copies that vary in number in different cells of the same individual. This genetic insult is thought to cause ALS/FTD via three non-mutually exclusive mechanisms: (1) loss of function due to decreased expression of C9ORF72 protein, (2) RNA toxicity from bidirectionally transcribed sense (GGGGCC) and antisense (CCCCGG) transcripts, and (3) proteotoxicity from dipeptide repeat (DPR) proteins produced from the expanded nucleotide repeats³.

This study focuses on the molecular mechanisms underlying DPR toxicity. Strong evidence suggests that DPRs are toxic in both cell culture and animal models of disease^4,5. Despite the presence of the expanded G4C2 repeat in the non-coding region of the RNA and the absence of an AUG initiating codon, DPRs are translated in all three reading frames from both sense and antisense transcripts through a process called repeat-associated non-AUG (RAN) translation⁴. Poly-glycine-alanine (poly-GA), poly-glycine-proline (poly-GP), and poly-glycine-arginine (poly-GR) are produced from sense transcripts, whereas poly-proline-arginine (poly-PR), poly-proline-alanine (poly-PA), and poly-GP are generated from antisense transcripts^6,7,8. DPRs are present in neural cells of patients with C9orf72-associated ALS and FTD, indicating that RAN translation occurs in vivo^6,7,9,10. A number of potential causes for DPR toxicity have been proposed, including protein aggregation, impaired nucleocytoplasmic transport, and proteasome dysfunction⁵; however, the relative contribution of each DPR to disease pathogenesis remains unclear.

Recent in vitro and in vivo studies have identified non-canonical translation initiation factors as critical mediators of DPR production. For example, a recent study showed that the ribosomal protein eS25 (RPS25), which is required for efficient translation initiation at the internal ribosome entry site (IRES) of a number of viral and cellular RNAs^11,12, is also required for RAN translation of poly-GP from G4C2 repeats in yeast, fly, and induced pluripotent human stem cell models¹³. In addition, the eukaryotic translation initiation factor eIF3F, which is thought to control translation of hepatitis C viral (HCV) RNA by binding to the viral IRES¹⁴, regulates poly-GP production from G4C2 repeats in HEK293 cells¹⁵. Moreover, a fly study found that eIF4B and eIF4H are important for RAN translation of poly-GR from G4C2 transcripts¹⁶. Lastly, knockdown of eIF2A, an unconventional translation initiation factor used by cells under stress conditions^17,18,19, partially affected poly-GA production in HEK293 cells and neural cells of the chick embryo²⁰. Collectively, these and other studies^21,22 suggest that multiple factors are involved in RAN translation of DPRs from G4C2 transcripts; yet, their identity and molecular mechanisms of action remain elusive.

To identify factors involved in RAN translation of DPRs in vivo, we developed two C. elegans models for C9orf72-associated ALS/FTD. C. elegans provides a powerful system for the study of molecular and cellular mechanisms underlying neurodegenerative disorders due to: (1) its short lifespan (~3–4 weeks), (2) its compact nervous system (302 neurons in total), (3) the ability to study neuronal morphology and function with single-cell resolution, (4) the fact that most C. elegans genes have human orthologs, and (5) the ease of genomic engineering and transgenesis, which enables the rapid generation of worms that harbor human gene mutations, permitting in vivo modeling of neurodegenerative disorders.

In this study, we initially developed C. elegans transgenic animals that carry, under the control of a ubiquitous promoter, 75 copies of the G4C2 repeat flanked by intronic C9orf72 sequences. Compared to controls, these animals produce DPRs (poly-GA, poly-GP, poly-GR), and display evidence of neurodegeneration, as well as locomotor and lifespan defects. A second set of transgenic worms expressing the 75 G4C2 repeats and the flanking intronic sequences exclusively in neurons displayed similar phenotypes, suggesting that DPR production in this cell type is sufficient to cause disease phenotypes. These C. elegans models provide an opportunity to study in vivo the molecular mechanisms underlying DPR production. Through a candidate approach, we identified a role for the non-canonical translation initiation factor eif-2D (ortholog of human eIF2D) in RAN translation of G4C2 repeats. Genetic removal of eif-2D did not affect the formation of G4C2 RNA foci, but prominently decreased poly-GA steady-state levels, mildly affected poly-GP levels, and improved locomotor activity and lifespan in both C. elegans models. Supporting the phylogenetic conservation of our C. elegans findings, in vitro knockdown of eIF2D in mouse and human cells led to a similar decrease in poly-GA steady-state levels. Together, these observations suggest eIF2D may play an important role in RAN translation from G4C2 repeats, a finding with biomedical implications for C9orf72-associated ALS and FTD.

Results

Generation of a C. elegans model for C9orf72-mediated ALS/FTD

The C. elegans genome contains a C9orf72 ortholog (alfa-1), which is involved in lysosomal homeostasis, cellular metabolism, and stress-induced neurodegeneration^23,24,25, however, alfa-1 does not contain G4C2 repeats. Therefore, to study the molecular mechanisms underlying DPR production from G4C2 repeats, we generated worms that carry a transgene encoding 75 copies of the G4C2 sequence under the control of a ubiquitous (snb-1) promoter²⁶ (Fig. 1a). The widespread expression of this promoter was independently validated (Supplementary Fig. 1). These 75 G4C2 copies are flanked with intronic sequences normally found upstream (113 nucleotides) and downstream (99 nucleotides) of the G4C2 repeats in the human C9orf72 gene (Fig. 1a). To monitor the expression of poly-GA, the most amyloidogenic DPR^27,28, a nanoluciferase (nLuc) reporter was placed in the poly-GA reading frame. Hereafter, we will refer to these transgenic animals as C9 ^ubi (Fig. 1a). In parallel, we generated four control C. elegans strains: (a) UAG ^ubi worms carry an identical sequence to the C9 ^ubi animals, but the upstream translation initiation codon CUG, which is required for translation of poly-GA in vitro^20,29,30,31, is mutated to UAG (Fig. 1a), (b) ΔC9 ^ubi worms lack the G4C2 repeats and the intronic sequences flanking the G4C2 repeats (Fig. 1a), (c) ΔG4C2 repeats ^ubi worms lack the G4C2 repeats, but maintain the intronic sequences (Supplementary Fig. 2a), and (d) the C9 ΔnLuc ^ubi worms carry an identical sequence to the C9 ^ubi animals, but lack nLuc (Supplementary Fig. 2a).

**Fig. 1: A C. *elegans* model for *C9orf72*-mediated ALS/FTD.**

Several independent transgenic lines for C9 ^ubi, UAG ^ubi, ΔC9 ^ubi, ΔG4C2 repeats ^ubi, and C9 ΔnLuc ^ubi worms were generated and tested as follows. First, we performed quantitative PCR with reverse transcription (RT-qPCR) and found that mRNA corresponding to intronic sequences that flank the G4C2 repeats is only detected in C9 ^ubi, UAG ^ubi, ΔG4C2 repeats ^ubi, and C9 ΔnLuc ^ubi animals, whereas nLuc mRNA is only detected in C9 ^ubi, UAG ^ubi, and ΔG4C2 repeats ^ubi animals (Fig. 1b and Supplementary Fig. 2b, c). Second, we sought to evaluate whether G4C2 transcripts form RNA foci in our transgenic animals, similar to observations made in other C9orf72 models^32,33. RNA fluorescent in situ hybridization (FISH) revealed G4C2 RNA foci in head and tail neurons, ventral nerve cord motor neurons, as well as non-neuronal cells in C9 ^ubi and UAG ^ubi, but not in control (ΔC9 ^ubi) animals (Fig. 1c and Supplementary Fig. 3a).

Next, we tested whether DPRs (poly-GA, poly-GP, poly-GR) from the G4C2 sense transcript are produced in the C9 ^ubi animals. We focused on these because the 75 G4C2 repeats are downstream of the snb-1 promoter, suggesting the sense transcript may be the one primarily transcribed and translated. Western blotting and luciferase assays showed that poly-GA was robustly expressed in C9 ^ubi worms when compared to ΔC9 ^ubi, UAG ^ubi, and ΔG4C2 repeats ^ubi control animals (Fig. 1d–f and Supplementary Fig. 3b). Corroborating these observations, immunofluorescence staining revealed the presence of poly-GA aggregates in head neurons, ventral nerve cord motor neurons, and non-neuronal cells of C9 ^ubi animals (Fig. 1i). We made similar observations in C9 ΔnLuc ^ubi worms (Supplementary Fig. 3c).

To evaluate potential age-dependent aggregation of poly-GA, we took advantage of the optical transparency of C. elegans and generated a GFP version of the C9 ^ubi animals (termed C9-GFP ^ubi) by replacing nLuc with GFP. Similar to mouse C9orf72 models^33,34, we indeed observed an age-dependent poly-GA::GFP aggregation in neurons and non-neuronal cells of C9-GFP ^ubi animals (Supplementary Fig. 4).

Although we did not detect poly-GP or poly-GR with western blotting (Supplementary Fig. 5a), more sensitive ELISA assays detected robust expression of poly-GP and modest production of poly-GR in C9 ^ubi worms, above the background level, observed in ΔC9 ^ubi controls (Fig. 1g, h). The background levels of poly-GP and poly-GR likely reflect the abundance of GP and GR motifs in the C. elegans proteome. Collectively, the above results demonstrate that RAN translation occurs in C. elegans.

Lastly, our findings in UAG ^ubi animals show that mutation of the non-canonical initiation codon CUG did not affect C9orf72 mRNA levels nor the formation of G4C2 RNA foci (Fig. 1c), but dramatically reduced poly-GA production (Fig. 1d–f). In contrast, the levels of poly-GP and poly-GR were not reduced in UAG ^ubi animals (Fig. 1g, h). We also confirmed this finding in HEK293 cells in vitro (Supplementary Fig. 5b, c), consistent with a previous report in human induced pluripotent stem cell (iPSC)-derived motor neurons³⁵. Interestingly, the nLuc reporter gene is translated in ΔG4C2 repeats ^ubi animals, which lack G4C2 repeats but carry the intronic C9orf72 sequences including the upstream CUG (Supplementary Fig. 6). However, it remains unclear whether this CUG can initiate translation in the absence of G4C2 repeats.

Importantly, we found that the median survival of C9 ^ubi worms is significantly shorter when compared to ΔC9 ^ubi and UAG ^ubi controls (P < 0.0001) (Fig. 2a and Supplementary Fig. 7a–c). The lack of an effect on median survival of UAG ^ubi animals suggests that the G4C2 RNA foci present in these animals do not affect organismal survival. Together, these findings suggest that one or more of the three DPRs (poly-GA, poly-GP, poly-GR) generated from the 75 G4C2 repeats in the C9 ^ubi animals likely contribute to the reduced survival of these animals, thereby establishing a C. elegans model for C9orf72-mediated ALS/FTD.

**Fig. 2: Evidence for motor neuron degeneration and synaptic defects in C9 ^ubi animals.**

C9 ^ubi animals display progressive locomotion defects and motor neuron degeneration

At the level of animal behavior, we conducted swimming and crawling assays on C9 ^ubi worms. The swimming assay was performed in a longitudinal fashion at juvenile (larval stage 4, L4) and adult (days 2 and 5) stages. By quantifying the rate of body flexion while animals are swimming, we found an age-dependent defect in C9 ^ubi animals compared to three control strains (ΔC9 ^ubi, UAG ^ubi, ΔG4C2 repeats ^ubi) (Fig. 2b and Supplementary Fig. 7d). Next, we performed a high-resolution behavioral analysis of freely crawling adult (day 2) C. elegans using automated worm tracking technology^36,37. This analysis can quantitate several features related to locomotion (e.g., velocity, crawling amplitude, body curvature). We found multiple locomotor defects in C9 ^ubi animals, such as reduced velocity and impaired body curvature (Supplementary Figs. 8–10). These defects were not present in ΔC9 ^ubi and UAG ^ubi, and ΔG4C2 repeats ^ubi controls, indicating that a hallmark of ALS, namely motor deficits, is recapitulated in the C9 ^ubi animal model. Crawling defects were also present in older (adult day 6) C9 ^ubi animals, but not in ΔC9 ^ubi and UAG ^ubi controls (Supplementary Videos 1–3). The presence of locomotion and survival defects in C9 ^ubi, but not UAG ^ubi animals is unlikely to be a result of different G4C2 mRNA amounts since both showed comparable mRNA levels (Fig. 1b).

The locomotion defects could be attributed, at least partially, to the degeneration of ventral nerve cord motor neurons, which are essential for C. elegans locomotion. To test this possibility, we fluorescently labeled the cholinergic motor neurons present in the nerve cord of C9 ^ubi and ΔC9 ^ubi animals with the unc-17/VAChT::gfp transgenic reporter, which allows for single-cell resolution in our analysis (Fig. 2c, d). Next, we quantified the number of cholinergic motor neurons (unc-17/VAChT::gfp positive) in C9 ^ubi and ΔC9 ^ubi animals at juvenile (L4) and adult (days 2 and 5) stages. Although no differences were observed at L4 and day 2, we found a significant reduction in the number of motor neurons that populate the nerve cord of C9 ^ubi animals at day 5 (Fig. 2e), arguing for progressive motor neuron degeneration. Because the snb-1 promoter is broadly active, we questioned whether other neuron types also degenerate. Although a similar longitudinal analysis did not reveal dopaminergic neuron degeneration (Supplementary Fig. 11), we cannot exclude the possibility that other neuron types in addition to cholinergic neurons also degenerate in C9 ^ubi animals.

DPR production selectively in neurons is sufficient to cause disease phenotypes in vivo

We found that poly-GA is present both in neuronal and non-neuronal cells of C9 ^ubi animals because the snb-1 promoter is active in multiple cell types (Fig. 1i and Supplementary Fig. 4a, b). To test whether DPR production from the G4C2 repeats exclusively in neurons is sufficient to cause disease-associated phenotypes, we generated a second set of transgenic animals by replacing the snb-1 promoter with a fragment of the unc-11 promoter (unc-11 prom8) known to be exclusively active in all C. elegans neurons²⁶. We refer to these animals as C9 ^neuro, ΔC9 ^neuro, and UAG ^neuro (Fig. 3a). First, we confirmed by RT-qPCR that the G4C2 repeat RNA (with C9orf72 intronic mRNA) and the nLuc mRNA are transcribed in C9 ^neuro and UAG ^neuro animals at comparable levels (Fig. 3b, c). Similar to C9 ^ubi animals, we found through western blotting that poly-GA is robustly produced in C9 ^neuro animals, but not in control animals lacking G4C2 repeats and intronic sequences (ΔC9 ^neuro) or in animals having the non-canonical translation initiation codon CUG mutated to UAG (UAG ^neuro) (Fig. 3d, e). Importantly, we found a dramatic decrease in the median survival of C9 ^neuro animals when compared to ΔC9 ^neuro and UAG ^neuro controls (P-value < 0.0001) (Fig. 3f and Supplementary Fig. 12). Our findings establish C9 ^neuro animals as a model for C9orf72-mediated ALS/FTD, and further suggest that decreased levels of poly-GA proteins in neurons are sufficient to improve ALS/FTD-associated phenotypes.

**Fig. 3: DPR expression exclusively in neurons reduces C. *elegans* lifespan.**

Genetic removal of eif-2D/eIF2D reduces DPR production and ameliorates lifespan and locomotion defects in C9 ^ubi animals

The C9 ^ubi and C9 ^neuro worm models for C9orf72-mediated ALS/FTD offer a unique opportunity to uncover the molecular mechanisms responsible for RAN-translated DPRs from G4C2 repeats. Our results suggest that RAN translation of one DPR, poly-GA, in both in vivo models (C9 ^ubi and C9 ^neuro worms) requires the non-canonical initiation codon CUG (Figs. 1d–h and 3d, e). We, therefore, surveyed the literature for factors known to initiate translation via this codon. Two proteins, the eukaryotic translation initiation factors eIF2A and eIF2D, are known to deliver tRNAs to the CUG codon and initiate translation in vitro^38,39. A single ortholog for each factor is present in the C. elegans genome, that is, eif-2A for human eIF2A and eif-2D for human eIF2D. We, therefore, questioned whether eif-2A and/or eif-2D are necessary for DPR expression from the G4C2 repeats. To test this, we obtained mutant animals that carry strong loss-of-function (putative null) alleles for eif-2A (gk358198) or eif-2D (gk904876). Both alleles carry missense mutations resulting in a premature STOP codon: W136Amber for eif-2A (gk358198) and R25Opal for eif-2D (gk904876) (see “Methods” section). Since these mutant animals are viable and fertile, we crossed them to the C9 ^ubi worms and generated eif-2A (gk358198); C9 ^ubi and eif-2D (gk904876); C9 ^ubi animals. Next, we found via RT-qPCR that the G4C2 repeat RNA with flanking C9orf72 intronic sequence, as well as the nLuc mRNA are normally transcribed in both eif-2A (gk358198); C9 ^ubi and eif-2D (gk904876); C9 ^ubi animals (Fig. 4a, b), indicating that loss of eif-2A or eif-2D does not affect transcription or stability of the repeat RNA. Consistent with these observations, G4C2 RNA foci can be detected in eif-2D (gk904876); UAG ^ubi, and eif-2D (gk904876); C9 ^neuro animals (Supplementary Fig. 13). Of note, we found a prominent decrease in poly-GA steady-state levels in eif-2D (gk904876); C9 ^ubi compared to C9 ^ubi animals, but no effect in eif-2A (gk358198); C9 ^ubi animals (Fig. 4c, d), implicating eif-2D in poly-GA expression. A rescue assay further established a causal role for eif-2D in poly-GA expression (Supplementary Fig. 14). The observed rescue was partial likely due to the mosaic nature of the eif-2D rescuing transgene. Interestingly, we observed a modest but statistically significant decrease in poly-GP production in eif-2D (gk904876); C9 ^ubi animals (Supplementary Fig. 15), suggesting other factors, in addition to eif-2D, are also involved in poly-GP translation. We did not observe any effects on poly-GR expression in eif-2D (gk904876); C9 ^ubi animals (Supplementary Fig. 15).

**Fig. 4: Genetic removal of *eif-2D/eIF2D* in C9 ^ubi and C9 ^neuro animals suppresses poly-GA expression and ameliorates lifespan defects.**

Since eif-2D is necessary for steady-state levels of at least two of the DPRs, loss of eif-2D gene activity may improve survival in C9 ^ubi animals. Indeed, we found that the eif-2D (gk904876); C9 ^ubi animals display a normal lifespan, similar to ΔC9 ^ubi and UAG ^ubi animals (Fig. 4e and Supplementary Figs. 16, 17). Interestingly, the eif-2D (gk904876); UAG ^ubi animals also display a normal median survival despite producing G4C2 RNA foci (Supplementary Figs. 13a, 17 and 18), suggesting that the improved survival of eif-2D (gk904876); C9 ^ubi animals are due to decreased DPR (poly-GA and/or poly-GP) expression.

We next asked whether the locomotor defects of C9 ^ubi animals (detected by automated worm tracking) can be ameliorated upon genetic removal of eif-2D, and found this to be the case (Supplementary Figs. 8 and 9). Of note, eif-2D (gk904876) single mutants or eif-2D (gk904876); UAG ^ubi animals did not display any prominent locomotor defects compared to controls (ΔC9 ^ubi and UAG ^ubi) (Supplementary Fig. 19). In summary, this behavioral analysis on C9 ^ubi animals complements our molecular and survival assays (Fig. 4), providing compelling evidence that loss of eif-2D ameliorates the pathogenic phenotype associated with RAN translation of DPRs (poly-GA, poly-GP) from C9orf72 G4C2 nucleotide repeats.

Lastly, we crossed the eif-2D (gk904876) mutants to the C9 ^neuro animals to test whether neuronal eif-2D gene activity is critical for poly-GA production and animal survival. Although transcription of the G4C2 repeats (C9orf72 intronic mRNA) increased in eif-2D (gk904876); C9 ^neuro for unclear reasons (Fig. 4f, g), we found a prominent decrease in poly-GA production in these animals (Fig. 4h, i). Importantly, loss of eif-2D restored survival of C9 ^neuro animals to levels similar to ΔC9 ^neuro and eif-2D (gk904876) control animals (Fig. 4j and Supplementary Fig. 20). Similar to the case of eif-2D (gk904876);UAG ^ubi, the eif-2D (gk904876); UAG ^neuro animals also display a normal median survival (Supplementary Fig. 21).

eif-2D/eIF2D is broadly expressed and controls poly-GA steady-state levels independently of G4C2 repeat length

Eukaryotic translation initiation factors are often expressed broadly in many tissues, but the expression pattern of C. elegans eif-2D and its vertebrate orthologs remains unknown. Through CRISPR/Cas9 genome editing (SunyBiotech), we engineered an endogenous reporter allele (syb3364) by introducing the gfp-3xFlag sequence before the stop codon of eif-2d (Fig. 5a and see “Methods” section). This reporter showed cytoplasmic expression (consistent with the role of eif-2D in translation) in most, if not all, C. elegans tissues (Fig. 5a, b).

**Fig. 5: The SUI1 domain of eIF-2D is required for poly-GA production.**

Despite its broad expression, eif-2D does not appear to play a role in canonical translation because the loss of eif-2D gene activity in C. elegans did not affect the expression of an AUG-initiated green fluorescent protein (GFP) transgene or endogenous reporter alleles for two AUG-initiated transcription factors known to be expressed in C. elegans ventral nerve cord motor neurons (Supplementary Fig. 22). These findings together with the normal lifespan and locomotion pattern of eif-2d mutants (described above) suggest eif-2D does not broadly affect canonical translation in C. elegans, albeit we cannot exclude the possibility of eif-2D being required for translation of other AUG-initiated transcripts.

Next, we sought to determine whether eif-2D controls poly-GA steady-state levels independently of G4C2 repeat length. To test this, we generated transgenic animals that carry 5 G4C2 repeats, referred to as C9 5xG4C2 ^ubi, in which nLuc is in the poly-GA frame (Supplementary Fig. 23). Although the RNA levels of intronic C9orf72 and nLuc were similar between C9 5xG4C2 ^ubi and eif-2d (-); C9 5xG4C2 ^ubi animals, a luciferase assay showed that the level of nLuc (indicative of poly-GA expression) was significantly decreased in the eif-2d (-); C9 5xG4C2 ^ubi animals (Supplementary Fig. 23). These results together with the data on C9 ^ubi animals that carry 75 G4C2 repeats (Figs. 4 and 5) suggest that eif-2D controls poly-GA steady-state levels independently of G4C2 repeat length.

The SUI1 domain of eif-2D/eIF2D is required for poly-GA expression in C. elegans

To obtain mechanistic insights, we interrogated the protein domains of C. elegans eIF-2D. Similar to human eIF2D, we found a PUA domain at the N terminus and a SUI1 domain at the C-terminus of C. elegans eIF-2D (Fig. 5a). In eukaryotes, the SUI1 domain is found in translation initiation factors eIF1 and DENR³⁸. Because SUI1 is important for accurate translation initiation codon recognition by eIF1^40,41, we hypothesized that the SUI1 domain of C. elegans eIF-2D is required for DPR translation. To test this, we first employed CRISPR/Cas9 genome editing and selectively replaced the SUI1 domain with a 3xFLAG epitope (Fig. 5a). Homozygous animals lacking the SUI1 domain (termed eif-2D ^ΔSU1I) expressed a truncated eIF-2D protein (Supplementary Fig. 24) and were viable. When crossed to C9 ^ubi, we observed a prominent reduction in poly-GA expression with no change in the levels of C9orf72 intronic mRNA (Fig. 5c–e). Second, we tested animals carrying the gk561128 allele that generates a nonsense mutation (Q512Ochre) within the SUI1 domain (Fig. 5a). Again, we observed a strong reduction in poly-GA expression, but no effect on C9orf72 intronic mRNA (Fig. 5a, f–h). These observations strongly suggest the SUI1 domain of eIF-2D has a key role in poly-GA translation.

Knockdown of eIF2D suppresses poly-GA production in mammalian cells

The prominent reduction of poly-GA in eif-2D mutants suggests that C. elegans eIF-2D plays a crucial role in poly-GA translation (Figs. 4 and 5). To extend these findings to mammalian cells, we transfected mouse NSC-34 motor neuron-like cells with a monocistronic construct carrying 75 G4C2 repeats and flanking C9orf72 intronic sequences (Fig. 6a), similar to the one used to generate the C9 ^ubi animals (Fig. 1a). shRNA-mediated knockdown of eIF2D in NSC-34 cells resulted in a strong reduction of poly-GA (Fig. 6b–d), similar to the effects observed with C. elegans eif-2D mutants. Compared to control shRNA, eIF2D shRNA did not affect poly-GP and poly-GR steady-state levels in these cells (Fig. 6e, f).

**Fig. 6: Knockdown of eIF2D suppresses DPR expression in NSC-34 and HEK293 cells.**

Next, we employed an in vitro platform to differentiate iPSC-derived motor neurons from a healthy individual and two ALS patients with G4C2 repeat expansions (see “Methods” section), (Supplementary Fig. 25). Despite using a sensitive ELISA method, we were unable to detect poly-GA expression above background levels in the iPSC-derived motor neurons from these specific ALS patients, preventing us from testing the role of eIF2D in poly-GA translation in these cells (Supplementary Fig. 26). Future experiments with additional iPSC lines from other ALS patients carrying long G4C2 repeats could help clarify the role of human eIF2D in poly-GA production. However, we did detect poly-GR and poly-GP in these iPSC-derived motor neurons. Similar to our findings in C. elegans and NSC-34 cells, siRNA-mediated knockdown of eIF2D had no effect on poly-GR (Supplementary Fig. 26). As in NSC-34 cells, we also observed no difference in poly-GP expression after eIF2D knockdown (Supplementary Fig. 26), which together with the small effect on poly-GP steady-state levels observed in C. elegans eif-2D mutants suggest that multiple translation initiation factors control poly-GP expression (see “Discussion” section and Table 1).

Table 1 Summary of effects on DPRs with eif-2D/eIF2D decrease.

Full size table

Our data with monocistronic G4C2 constructs in C. elegans (Figs. 4 and 5), and mouse NSC-34 cells (Fig. 6a–f) are complemented with in vitro data in human HEK293 cells transfected with a bicistronic construct carrying 75 G4C2 repeats and flanking intronic sequences in the second cistron (Fig. 6g and Table 1). To monitor the expression of different DPRs, we generated three different versions of this construct by inserting nLuc in the poly-GA, poly-GP, or poly-GR reading frame (Fig. 6g). In the transfected cells, we robustly detected all three DPRs (Fig. 6h–m). Similar to our findings in C. elegans eif-2D mutants, eIF2D knockdown decreased poly-GA and poly-GP (Fig. 6h–k), whereas eIF2D overexpression increased DPR production (Supplementary Fig. 27). Importantly, the protein levels of fLuc, which is expressed by the first cistron via canonical AUG-dependent translation, were similar in cells transfected with either control or eIF2D shRNAs (Fig. 6n), suggesting a specific role for eIF2D in non-canonical translation in human cells. Interestingly, we also observed an effect on poly-GR upon eIF2D knockdown in HEK293 cells transfected with the bicistronic construct (Fig. 6k). We surmise the way DPR translation is initiated in this construct is likely quite different from the monocistronic constructs used in the worm and NSC-34 cells, and from the endogenous human C9ORF72 locus. Taken together, our in vivo (C. elegans) and in vitro (NSC-34, HEK293) data uncovered a conserved role for eIF2D in controlling the steady-state levels of at least one DPR (poly-GA). Table 1 summarizes the observed effects on DPRs upon eif-2D/eIF2D knockdown in vivo (C. elegans) and in vitro (NSC-34, HEK293, human iPSC-derived motor neurons).

eif-2D/eIF2D does not modulate phosphorylation of eukaryotic initiation factor-2α (eIF2α)

A growing body of evidence suggests that phosphorylation of eIF2α as a result of activation of the integrated stress response (ISR) leads to increases in DPR production^29,42. We, therefore, wondered whether eIF2D is involved in stress-activated phosphorylation of eIF2α. However, we found no significant differences in phosphorylated eIF2α levels between wild-type and eif-2D mutant animals carrying the C9 ^ubi transgene (Supplementary Fig. 28). Furthermore, eIF2D knockdown does not affect the level of p-eIF2α in HEK293 cells following administration of a known ER stressor (sodium arsenite) (Supplementary Fig. 29). Lastly, administration of the proteasome inhibitor MG132 in this cellular system did not affect the results of eIF2D knockdown on RAN translation (Supplementary Fig. 30). Altogether, our findings suggest eif-2D/eIF2D controls DPR steady-state levels without altering the levels of p-eIF2α.

Discussion

The discovery of RAN translation of C9orf72 nucleotide repeats combined with the reported toxicity of DPRs in model systems have focused the ALS/FTD field on this unconventional form of translation, as well as on DPRs as potential therapeutic targets. To study the molecular mechanisms underlying RAN translation, we initially developed a C. elegans model that carries a transgene encoding 75 copies of the G4C2 repeat flanked by intronic C9orf72 sequences under the control of a ubiquitous promoter. These C9 ^ubi animals produce three DPRs from the sense transcript, namely poly-GA, poly-GP, and poly-GR, and show signs of neurodegeneration, as well as locomotor and lifespan defects. Such phenotypes are likely due to DPR toxicity because mutation of a non-canonical CUG initiation codon selectively decreased poly-GA production and ameliorated locomotor and lifespan defects in C9 ^ubi animals without affecting C9orf72 mRNA levels or the formation of G4C2 RNA foci. Moreover, a second C. elegans model (C9 ^neuro) that carries a similar transgene exclusively expressed in neurons displayed a similar phenotype. Importantly, we found that three loss-of-function mutations in the eukaryotic translation initiation factor eif-2D/eIF2D suppressed DPR expression (poly-GA, poly-GP) and ameliorated lifespan defects in both C9 ^ubi and C9 ^neuro models. Mechanistically, we found the conserved SUI1 domain at the C-terminus of eIF-2D/eIF2D is required for DPR (poly-GA) expression. Lastly, our in vitro findings in mouse and human cells combined with our C. elegans data (Table 1) suggest a conserved role of eif-2D/eIF2D in RAN translation.

The C9 ^ubi and C9 ^neuro worm models offer insights into DPR toxicity

An unresolved issue in the field of ALS and FTD research is the relative contribution of each of the five DPRs (poly-GA, poly-GP, poly-GR, poly-PR, poly-PA) to disease pathogenesis. In this paper, two lines of evidence indicate that poly-GA, the most readily detected DPR in the brain and spinal cord of ALS/FTD patients with C9orf72 expanded repeats^43,44, significantly contributes to disease phenotypes in C. elegans: (1) poly-GA aggregates and appears to be the most abundantly expressed DPR in our worm models, and (2) mutation of the non-canonical CUG initiation codon selectively decreases poly-GA production, and ameliorates locomotor and lifespan defects in C9 ^ubi and C9 ^neuro animals. Importantly, these in vivo results significantly extend previous reports demonstrating that this same CUG is required in vitro for poly-GA translation^20,29,30,31. Of note, mutation of this CUG to UAG both in C. elegans (Fig. 1) and an in vitro cellular system (Supplementary Fig. 5) did not affect poly-GP and poly-GR translation, suggesting different near-cognate translation initiation codons are used for each DPR. Indeed, an AGG located 1 nt upstream of the repeat has been reported to initiate translation of poly-GR³¹. Despite the above findings, we cannot rule out the possibility that a frameshift occurs in DPR translation upon CUG mutation, as found by other investigators³⁰.

In support of our C. elegans findings, recent studies in mice reported neurodegeneration, motor deficits, and cognitive defects following ubiquitous expression of poly-GA⁴⁵, as well as behavioral abnormalities following spinal cord expression of poly-GA⁴⁶. A prevailing hypothesis is that poly-GA causes cellular toxicity through proteasomal impairment and protein sequestration⁵. A recent publication reports that poly-GA spreads cell-to-cell in an in vitro system and inhibits proteasomal function both cell-autonomously and non-cell-autonomously, leading to ubiquitination of the nuclear localization signal of TDP-43 and its subsequent cytoplasmic mislocalization⁴⁷. Importantly, treatment with an antibody against poly-GA ameliorated TDP-43 mislocalization⁴⁷, as well as toxicity in mouse models of mutant C9orf72-induced ALS/FTD⁴⁸. A zebrafish model that produces poly-GA did not exhibit motor axon toxicity⁴⁹, however, this may be due to low poly-GA expression.

Our C9 ^ubi worm model also produces poly-GP and poly-GR. poly-GP is thought to be relatively nontoxic⁵ compared to poly-GR, which has been demonstrated to be toxic in mouse neurons³⁴. In C. elegans, codon-optimized constructs driving expression of poly-GR or poly-PR caused toxicity in muscles and neurons⁵⁰. Furthermore, initiation of poly-GR translation has been reported to occur at the same upstream CUG codon used for poly-GA production, but with subsequent frameshifting into the GR reading frame³⁰. However, two recent papers state that translation initiation of poly-GR did not occur from this upstream CUG codon^31,35. Because we detected poly-GR in our C. elegans model (Fig. 1 and Supplementary Fig. 15), it is possible that poly-GR contributes to the observed disease phenotypes. Supporting this notion, very low levels of poly-GR in neurons have been reported to impair synaptic function and induce behavioral deficits in both Drosophila and mice³⁴.

In addition to what appears to be DPR toxicity in our C. elegans models, there remains the question as to whether the repeat RNA itself rather than, or in addition to, its protein product could be toxic⁵¹. A role for RNA toxicity does not appear to be the case in our nematode experiments since mutation of the non-canonical initiation codon CUG to UAG led to a significant decrease in poly-GA expression and rescue of worm survival to wild-type levels, but had no effect on C9orf72 mRNA levels nor G4C2 RNA foci formation. It is possible, however, that the CUG > UAG mutation, albeit minimal in nature, can affect RNA structure.

One question that arises is whether our transgenic C9 ^ubi and C9 ^neuro animals constitute an appropriate model for the patient with C9orf72 expanded repeats. It is clear that the RNA template (repeat RNA plus flanking intronic sequence) produced in our C. elegans animals differs from the RNA template actually expressed in the central nervous system of ALS/FTD patients with a C9orf72 expanded repeat. The human G4C2 expanded repeat varies in length in patients and even in different cells within the same patient. The latter finding suggests that a number of potential toxicities—besides one related to DPR production—may be present in the human disease state, including toxicity related to repeat RNA and/or synthesis of other DPRs. Toxicity may also occur as a consequence of a decrease in the authentic C9orf72 gene product, consistent with a recent study reporting that a decrease in C9ORF72 protein leads to a decrease in autophagic clearance of toxic accumulations of the DPRs³¹.

eif-2D/eIF2D regulates poly-GA expression from G4C2 nucleotide repeats

eIF2D is known to initiate translation in vitro at both AUG and non-AUG initiation codons^38,52. The present study demonstrates a key role of eIF2D in poly-GA expression since eIF2D knockdown in two cellular systems (mouse NSC-34 and human HEK293 cells) and three different eif-2D loss-of-function alleles in C. elegans led to a prominent decline in poly-GA steady-state levels (Table 1). It is noteworthy that genetic removal of eif-2D in C. elegans does not appear to have an effect on (a) canonical AUG-initiated translation of three tested mRNAs (Supplementary Fig. 22), (b) animal locomotion, and (c) lifespan. The absence of detrimental phenotypes in C. elegans animals globally lacking eif-2D/eIF2D makes this factor an attractive therapeutic target.

What is the mechanism through which eif-2D/eIF2D controls poly-GA steady-state levels? We and others found that poly-GA translation is initiated from a CUG (−24nt upstream of G4C2)^20,29,30,31, and a recent study showed that Met-tRNA is used for initiation of poly-GA translation at this CUG³¹. A previous study showed that both Met-tRNA and non-Met-tRNA are delivered by eIF2D to the P-site of the 40S ribosomal subunit during translation initiation at the HCV IRES in HEK293 cells³⁸. Additional cryo-electron microscopy results showed that the SUI1 domain of eIF2D contacts the codon–anticodon duplex on the HCV IRES, and also contacts Met-tRNA, presumably stabilizing its orientation^53,54. Besides eIF2D, the SUI1 domain is also present in two other non-canonical initiation factors, eIF1 and DENR³⁸. It has been proposed that eIF2D may act by changing the conformation of the 40S ribosomal subunit in a manner similar to eIF1, but unlike eIF1, eIF2D stabilizes tRNA binding within the P-site³⁸. Using genome engineering in C. elegans, we found the SUI1 domain is required for poly-GA steady-state levels. This observation together with the similar effects on DPR expression observed in eif-2D (-); C9 ^ubi and UAG ^ubi animals favor a model in which eIF-2D acts at the CUG codon to deliver the Met-tRNA (which is necessary for poly-GA initiation) to the P-site of the 40S ribosomal subunit. However, it is important to acknowledge that eIF2D has additional functions besides translation initiation. For example, eIF2D was implicated in recycling 40S ribosomal subunits^55,56,57, which enabled ribosomes and mRNAs to participate in multiple rounds of translation, leading to efficient protein expression. It is thus possible that genetic removal of eif-2D in our worm models caused inefficient DPR production by more than one mechanism.

Multiple factors are involved in DPR translation from G4C2 nucleotide repeats

As mentioned in Introduction, recent studies suggest multiple factors (e.g., RPS25, eIF3F, eIF4B, eIF4H) are involved in RAN translation of DPRs from G4C2 transcripts. It remains unclear though to what extent the production of each DPR is controlled by these factors, in part because studies often focus on a single DPR. We provide evidence both in C. elegans and two cell culture systems (mouse NSC-34 and human HEK293 cells) that eif-2D/eIF2D controls the steady-state levels of poly-GA. Moreover, our C. elegans data suggest a minor role for eif-2D/eIF2D in poly-GP expression and no effect on poly-GR, suggesting that the production of each DPR may involve additional factors. Consistent with this notion, RPS25 knockdown in vitro reduced poly-GA by 90%, poly-GP by 50%, and poly-GR by 30%¹³. A promising candidate to work together with eIF2D is DENR, another initiation factor shown in a recent fly study to act redundantly with eIF2D during development and integrated stress response⁵⁸. Of note, it is possible that these factors do not control each other’s expression based on our findings with a C. elegans ortholog of eIF4B and eIF-2D (Supplementary Fig. 31). Collectively, these and other studies¹⁶ suggest that a number of different factors play critical roles in RAN translation of DPRs.

Our previous study demonstrated that knockdown of eIF2A in HEK293 cells and neural cells in the chick embryo led to a modest (30%) decrease in poly-GA expression from G4C2 expanded repeats²⁰. A recent study also implicated eIF2A in RAN translation from CCUG and CAGG repeats in myotonic dystrophy type 2 (DM2)⁵⁹. In the present study, however, eif-2A/eIF2A deficiency had no effect on poly-GA expression in C. elegans, while eIF2D knockdown in NSC-34 and HEK293 cells and eif-2D knock-out in C. elegans had a prominent effect on poly-GA expression. These results suggest that eIF2D plays a more important role in RAN translation than eIF2A. It is possible, however, that eIF2A also plays a significant role in RAN translation from G4C2 expanded repeats, but only upon cellular stress since it can translate a subset of mRNAs when eIF2α is phosphorylated^17,18,60. We note that eIF2D does not control the levels of phosphorylated eIF2α in C. elegans and HEK293 cells (Supplementary Figs. 27 and 28).

RAN translation occurs in C. elegans and offers the opportunity to discover conserved regulators

Two previous studies reported DPR-associated toxicity in C. elegans by using either a codon-optimized construct that carries no G4C2 repeats, or a construct that carries 66 G4C2 repeats^22,50. The latter study strongly indicated that RAN translation occurs in the worm. However, the non-canonical (non-AUG) initiating codon and translation initiation factor remained elusive. By generating C. elegans animals that carry 75 G4C2 repeats flanked by intronic C9orf72 sequences and subsequently blocking poly-GA expression by mutating a non-canonical initiation codon (CUG) upstream of the repeats, we advanced the molecular understanding of how RAN translation occurs in the worm. This finding in C. elegans, together with previous reports in yeast and flies^16,22, strongly suggest that the molecular machinery required for RAN translation is evolutionary conserved, offering an opportunity to use simple model systems for the discovery of RAN translation regulators.

In summary, we leveraged the specific strengths of the C. elegans model and discovered that the non-canonical initiation factor eif-2D/eIF2D is required for DPR expression (poly-GA, poly-GP) from expanded G4C2 repeats in the C9orf72 gene. Our in vitro findings argue for a conserved role of eif-2D/eIF2D in poly-GA expression, which could be potentially used to pursue directions for C9orf72-associated ALS and FTD therapy. In fact, because RAN translation of other nucleotide repeat expansions (not G4C2) occurs in several neurodegenerative diseases⁴, eIF2D could be investigated as a therapeutic target in these disorders as well.

Methods

C. elegans strains

Worms were grown at 15, 20, or 25 °C on nematode growth media (NGM) plates supplied with E. coli OP50 as food source⁶¹. Mutant alleles used in this study include eif-2A (gk358198), eif-2D (gk904876), and eif-2D (gk561128), which were backcrossed three times to the wild-type (N2) strain. The following strains were generated using CRISPR/Cas9 genome editing by SunyBiotech. The strain PHX3364 with genotype eif-2D (syb3364) is an endogenous reporter for eif-2d because the GFPnovo2-3xFLAG sequence has been inserted before the stop codon. The strain PHX3432 with genotype eif-2D (syb3432) carries a replacement of the SUI1 domain with a 3xFLAG sequence. A complete list of all primers used in this study is provided in Supplementary Table 1.

Generation of transgenic C. elegans animals

The template for the generation of the plasmids used in the C9 ^ubi, ΔC9 ^ubi, UAG ^ubi and C9 5xG4C2 ^ubi animals has been previously described in an in vitro study²⁰. In C9 ^ubi animals, the plasmid has 75 G4C2 repeats with 113 nucleotides 5′ and 99 nucleotides 3′ of intronic sequences that normally flank the G4C2 repeats in the human C9orf72 gene; this sequence is followed by nanoluciferase (nLuc) reporter in the reading frame of poly-GA, which is followed by the unc-54 3′ UTR. In ΔC9 ^ubi animals, the construct lacks the G4C2 repeats and the flanking intronic sequences. In UAG ^ubi animals, the construct is identical but the non-canonical translation-initiating codon CUG is mutated to UAG. The promoter sequences of the snb-1 and unc-11 genes are shown in Supplementary Data 1. The unc-54 3′ UTR was cloned into the XhoI-SacI site of the plasmids.

To generate the ΔG4C2 repeats ^ubi construct, ΔG4C2-1-F/R and ΔG4C2-2-F/R fragments were phosphorylated, annealed, and then ligated into restriction sites of HindIII and NotI of the C9 ^ubi construct. To generate the C9 ΔnLuc ^ubi construct, the NotI-ΔnLuc-BamHI-F/R fragment was inserted into restriction sites of NotI and BamHI of the C9 ^ubi construct. For the 3xFlag-eif-2D ^ubi construct, the 3xFlag sequence (synthesized by Integrated DNA Technologies) was inserted into restriction sites of HindIII and NotI, and eif-2D cDNA was inserted into the restriction sites of NotI and BamHI of the C9 ^ubi construct. For the C9-GFP ^ubi construct, GFP novo2⁶² was inserted into restriction sites of NotI and BamHI of the C9 ^ubi construct.

The C9, UAG, ΔC9, ΔG4C2 repeats, C9 ΔnLuc, C9 5xG4C2, or C9-GFP constructs were microinjected into the C. elegans gonad at 100 ng/μl along with a myo-2:GFP or myo-2:mCherry plasmid (3 ng/μl), and a pBlueScript plasmid (20 ng/μl) (Supplementary Data 2). Multiple transgenic lines per construct were established (Supplementary Data 3). The resulting C9 ^ubi, ΔC9 ^ubi, and UAG ^ubi animals, as well as the resulting C9 ^neuro, ΔC9 ^neuro, and UAG ^neuro animals, carried these transgenes as extrachromosomal arrays. The exact extrachromosomal lines used in each experiment are indicated in figure legends and Supplementary Data 3. We also generated integrated versions of the ΔC9 ^ubi, C9 ^ubi, and UAG ^ubi constructs (Supplementary Data 3). One integrated line for each was obtained and outcrossed five times to a wild-type (N2) strain. In Supplementary Data 3, we also provide details on transgenes: vsIs48 [unc-17::gfp] and otIs181 [dat-1::mCherry+ttx-3::mCherry].

Lifespan assay

The lifespan assay was performed as previously described²². Worms were transferred at the L4 larval stage to NGM plates coated with OP50 bacteria in the presence or absence of 50 μM 5-fluoro-2’deoxyuridine (FUDR, Sigma). Worms were kept at 20 °C and scored every 2 or 3 days. If the worms did not respond to prodding the head with the wire spatula, they were scored as dead worms. In the assay with FUDR, the worms were moved to new plates before bacterial food was depleted. In the assay without FUDR, the worms were moved to new plates every 2 days. If we were unable to find the same number of worms on the plate after 2 days, they were scored as censored worms. Similar results were obtained when lifespan assays were performed with (Figs. 2a, 3f, and 4e, 4j) or without (Supplementary Figs. 17 and 21) FUDR. The day of the timed egg-laying was considered day 0 for lifespan analysis. The experiments were replicated two to three times. The exact number of biological replicates, censored animals, dead animals, and worms used in each trial is shown in Supplementary Figs. 7, 12, 16, 17, 20, and 21. The Mantel–Cox log-rank test was performed for statistical analysis.

Microscopy

Worms were anesthetized using 100 mM of sodium azide (NaN₃) and mounted on 5% agarose pads on glass slides. Images were taken using an automated fluorescence microscope (Zeiss, Axio Imager Z2) equipped with a Zeiss Axiocam 503 mono using the ZEN software (Version 2.3.69.1000, Blue edition). Representative images are shown following max-projection of 2–5 Z-stack images (each ~0.5 μm) using the maximum intensity projection type. Image reconstruction was performed using Image J software (version 2.0.0-rc-59/1.51k)⁶³.

Quantification of microscopy images

The number of neurons expressing the respective fluorescent reporter was quantified manually using Image J software (version 2.0.0-rc-59/1.51k)⁶³. Quantification was performed in a blinded fashion. Details related to the fluorescent reporter, as well as the number and stage of animals analyzed are provided in the respective figure legends.

Immunocytochemistry

C. elegans

Animals of the respective genotypes were grown at 20 °C on nematode growth media (NGM). We followed an immunocytochemical staining procedure described previously⁶⁴. In brief, worms were prepared for staining following the freeze-crack procedure and subsequently fixed in ice-cold acetone (5 min) and ice-cold methanol (5 min). Worms were transferred using a Pasteur pipette from slides to a 50 ml conical tube that contained 40 ml 1 × PBS. Following brief centrifugation (2 min, 1800 × g), worms were pelleted and 1 × PBS was removed. Next, worms were incubated with 300 μl of blocking solution (1 × PBS, 0.2% Gelatin, 0.25% Triton X100) for 30 min at room temperature (rolling agitation). Following removal of the blocking solution, worms were incubated overnight with a mouse anti-poly-GA antibody (1:25 in PGT solution, EMD Millipore). Next, the primary antibody solution was removed and worms were washed five times with washing solution (1 × PBS, 0.25% Triton X100). Worms were incubated with an Alexa Fluor 594 goat anti-mouse IgG secondary antibody (1:1000 in PGT solution, A-11020, Molecular Probes) for 3 h at room temperature. Following 5 washes, worms were mounted on a glass slide and examined with an automated fluorescence microscope (Zeiss, AXIO Imager Z1 Stand).

iPSC-derived motor neurons

Motor neurons were seeded onto a preplated mouse glial monolayer. After 50 days in culture, MNs were fixed with 4% paraformaldehyde for 15 min at RT. Cells were then washed with PBS and blocked/permeabilized for 2 h in PBS containing 0.25% Triton and 10% normal donkey serum (Jackson ImmunoResearch, Cat # 017-000-001). Fixed MNs were then incubated overnight at 4 °C with primary antibodies: ChAT (goat, 1:150, Millipore, AB144P), ISLET 1/2 (mouse, 1:100, DSHB, 39.4D5), and MAP2 (chicken, 1:5000, Abcam, Ab5392). The following day, PBS + 0.1% Triton was used for 3–10 min washes. Samples were then incubated with secondary antibodies conjugated to Alexa488 (1:500, Life Technologies A-11055), Alexa555 (1:500, Life Technologies A-31570), and Alexa647 (1:500, Molecular Probes/Jackson ImmunoResearch), while cell nuclei were stained with DNA labeling Hoechst (1:500, Life Technologies, H21492).

RNA fluorescent in situ hybridization (FISH)

RNA FISH was carried out as previously described⁶⁵. For each genotype, well-fed worms at various stages and grown on 4–5 Petri dishes were fixed with fixation buffer (3.7% formaldehyde in PBS) for 1 h, and then resuspended in 70% ethanol overnight. The samples were washed with wash buffer (10% deionized formamide and 2 × SSC) and hybridized with 5 μM RNA probe (CCCCGGCCCCGGCCCCGG) conjugated with Quasar 670 at the 3′ end (LGC Biosearch Technologies) in hybridization buffer (10% (w/w) dextran sulfate, 10% deionized formamide, and 2 × SSC) overnight at 37 °C. The samples were then washed with wash buffer for 30 min at 37 °C, and subsequently resuspended with 5 ng/ml DAPI diluted in wash buffer for 30 min at 37 °C. After washing with 2 × SSC, the samples were resuspended in GLOX buffer (0.4% glucose, 10 mM Tris-HCl, pH8.0, 2 × SSC, 3.7 μg/ml glucose oxidase, and >300 units catalase), placed onto a slide, and examined with an automated fluorescence microscope (Zeiss, AXIO Imager Z1 Stand).

Automated worm tracking

Worms were maintained as mixed stage populations by chunking on NGM plates with E. coli OP50 as the food source. Worms were bleached and the eggs were allowed to hatch in M9 buffer to arrest as L1 larvae. L1 larvae were refed on OP50 and allowed to grow to day 2 or adulthood. On the day of tracking, five worms were picked from the incubated plates to each of the imaging plates (see below) and allowed to habituate for 30 min before recording for 15 min. Imaging plates were 35 mm plates with 3.5 ml of low-peptone (0.013% Difco Bacto) NGM agar (2% Bio/Agar, BioGene) to limit bacteria growth. Plates are stored at 4 °C for at least 2 days before use. Imaging plates were seeded with 50 μl of a 1:10 dilution of OP50 in M9 the day before tracking and left to dry overnight with the lid on at room temperature.

Behavioral feature extraction and analysis

All videos were analyzed using Tierpsy Tracker (Version 228) to extract each worm’s position and posture over time³⁶. These postural data were then converted into a set of behavioral features selected from a large set of features as previously described³⁶. For each strain comparison, we performed unpaired two-sample t-tests independently for each feature. The false discovery rate (FDR) was controlled at 5% across all strain and feature comparisons using the Benjamini Yekutieli procedure. The P-value threshold for this analysis (FDR 5%) was 0.0014.

Swimming behavior

Animals were grown at 15 °C until they were assayed at three different stages (L4, day 2, day 5).

Swimming rates were measured with 20 animals per genotype. Individual animals were placed on 40 μl of temperature-equilibrated M9 buffer on an agar plate. After 1 min of acclimatization, the number of changes in the direction of bending at the mid-body region was recorded for 30 s. Animals were chosen at random by assaying the first worm in the field of view.

In vitro studies with NSC-34 motor neuron-like cells

shRNA plasmids against mouse eIF2D were constructed by inserting annealed oligos into SgrAI and EcoRI sites of pFB-U6-shRNA-CMV-GFP vector⁶⁶. NSC-34 cells in a 6-well plate were transfected with either C9-3T plasmid alone or in combination with eIF2D shRNA using transfection reagent Attractene (Qiagen) according to the manufacturer’s protocol and cultured for 48 h. The NSC-34 cells are a gracious gift from Dr. Neil Cashman⁶⁷.

In vitro studies with HEK293 cells

Bicistronic plasmids were constructed, as previously described²⁰, with firefly luciferase (fLuc) in the first cistron and C9orf72 sequences in the second cistron, with or without a UAG replacing the CUG 24 nts upstream of the 75 G4C2 repeats.

shRNA plasmids against human eIF2D were prepared using previously published methods²⁰. In brief, oligonucleotides with an siRNA sequence were cloned into the BamHI and HindIII sites of psilencer 2.1-U6 neo vector (ThermoFisher Scientific) according to the manufacturer’s protocol. The control shRNA vector was provided in this kit. The eIF2D-V5 Tag plasmid was prepared by inserting human eIF2D cDNA (RC201726, Origene) into restriction sites of EcoRI and NotI of pcDNA6. The GFP-V5 Tag plasmid was prepared by inserting GFP sequence from pFB-U6-shRNA-CMV-GFP plasmids⁶⁶ into restriction sites of EcoRI and NotI of pcDNA6.

For western blotting (see below), HEK293 cells (ATCC, CRL-1573) were plated in 6-well plates at 2 × 10⁵ per well and cotransfected with 0.5 μg of bicistronic plasmids along with either 2.5 μg control shRNA or anti-eIF2D shRNA using Lipofectamine LTX (ThermoFisher Scientific). For luciferase assays (see below), the cells were plated in 24-well plates at 5 × 10⁴ per well and cotransfected with 100 ng of the bicistronic plasmid along with 500 ng of either control shRNA or anti-eIF2D shRNA using Lipofectamine LTX (ThermoFisher Scientific). For the eIF2D overexpression assay, cells were cotransfected with 20 ng of bicistronic plasmids along with 380 ng of either GFP-V5 Tag or eIF2D-V5 Tag plasmids using Lipofectamine LTX. The cells were cultured for 48 h in DMEM supplemented with 10% FBS, 2 mM l-Glutamine, 100 U/ml Penicillin and 100 μg/ml Streptomycin, and then processed.

In vitro differentiation of motor neurons from human induced pluripotent stem cells (iPSC)

Motor neuron cultures were prepared as described by Ortega et al.⁶⁸. Briefly, induced pluripotent stem cells (iPSCs) were dissociated using Accutase (Innovative Cell Technologies) and plated at a final density of 100,000 cells/cm² in mTESR1 (STEMCELL) supplemented with 10 μM ROCK inhibitor (DNSK International). Twenty-four hours later, the iPSC culture medium was changed to a differentiation medium (50% DMEM:F12, 50% Neurobasal, non-essential amino acids (NEAA), Glutamax, N2, and B27) (all from ThermoFisher Scientific). For the first 6 days, the differentiation culture medium was changed daily and supplemented with 10 μM SB432542 (DNSK International), 100 nM LDN-193189 (DNSK International), 1 μM Retinoic Acid (Sigma), and 1 μM SAG (DNSK International) to induce spinal neural progenitors. For the next 7 days, the differentiation culture medium was changed daily and supplemented with 5 μM DAPT (DNSK International), 4 μM SU5402 (DNSK International), 1 μM Retinoic Acid, and 1 μM SAG to generate spinal motor neurons. Following the differentiation, cells were dissociated with TrypLE Express (ThermoFisher Scientific) with DNase I (Worthington) and plated onto plastic culture plates coated with Matrigel (Corning). Motor neurons were fed every other day with MN medium (Neurobasal medium which is supplemented with Glutamax, N2, B27, NEAA, Hyclone FBS (Cytiva), 0.2 μg/ml Ascorbic Acid (Sigma), and 10 ng/ml each BDNF, CNTF, and GDNF) (all from R&D Systems)).

siRNA knockdown experiments

After 35 days in culture, motor neurons were transfected with a siRNA specific to eIF2D mRNA or a scrambled control. First, a lipofectamine-siRNA (ThermoFisher Scientific) complex was prepared separately for both the targeting and nontargeting siRNA in OptiMEM with incubation at room temperature for 20 min. After this period, the lipofectamine RNAiMAX (ThermoFisher Scientific)-siRNA solution was brought up to the appropriate volume with MN culture medium. The culture medium in the dish was then aspirated and replaced with a lipofectamine–siRNA solution at a final concentration of 60 pmol siRNA in 1.5 ml medium per 1,000,000 cells. Twenty-four hours later the medium was replaced with a normal MN medium. This procedure was repeated 2 more times at 40 and 45 days in culture. After 50 days in culture, motor neurons were lysed with RIPA buffer (10 mM Tris-HCL pH 8.0, 140 mM NaCl, 1 mM EDTA, 0.1% SDS) supplemented with protease inhibitors (Millipore) on ice for 10 min and sonicated using a microneedle sonicator. After removing the RIPA-insoluble fraction by centrifugation, the RIPA-soluble fraction was assessed for levels of the DPRs.

ALS patient iPSC line information

Control (18A) line previously characterized for pluripotency⁶⁹. Harvard University; RRID:CVCL_8993. Female, 48 years old.

C9 #1 (TALS9-11.2) line obtained from Target ALS. Cat# ND50008; RRID:CVCL_FA04. Female, 61 years old. Pluripotency certificate is provided in Supplementary File 1. This line is previously described in Ortega et al.⁶⁸, where repeat-primed PCR confirmed a large number of G4C2 repeats.

C9 #2 (ND10689) iPSC line was reprogrammed by and received from the Ichida Lab (University of Southern California). B-lymphocytes were originally purchased from Coriell. Cat# ND10689; RRID:CVCL_BE81. Female, 51 years old. Pluripotency status and presence of a G4C2 repeat expansion were previously described in Shi et al.⁷⁰. In the latter study, the G4C2 repeat size is ~14 kb for this line. Repeat-primed PCR in Ortega et al.⁶⁸ also confirmed a large number of G4C2 repeats.

Western blotting

Lysates of worms were prepared by sonication in buffer consisting of 4% urea and 0.5% SDS with 1 × Halt^TM Protease and Phosphatase inhibitor Cocktail (ThermoFisher Scientific). NSC-34 cell lysates were prepared using RIPA buffer (50 mM Tris-HCl, pH 7.5; 150 mM NaCL; 1% Triton-X 100; 0.1% SDS; 0.5% sodium deoxycholate; 2 mM EDTA and 10% glycerol) containing protease inhibitor cocktail (Sigma) and phosphatase inhibitor cocktail (Sigma). HEK293 cell lysates were prepared using RIPA buffer containing 1 × Halt^TM Protease and Phosphatase inhibitor Cocktail. These lysates were subjected to electrophoresis on 4–20% SDS polyacrylamide gels (Mini-PROTEAN TGX Gels, BIO-RAD), and then transferred to Amersham Hybond P 0.45 μm PVDF membranes (GE Healthcare). The membrane was blocked with 1% non-fat skim milk in Tris-buffered saline containing 0.05% Tween-20 for 1 h at room temperature, and then incubated overnight at 4 °C with primary antibodies against poly-GA (1:1000, MABN889, EMD Millipore), fLuc (1:1000, G7451, Promega), FLAG (1:300, F7425, Sigma), FLAG (1:1000, 9A3, Cell Signaling Technology), GFP (1:1000, D5.1, Cell Signaling Technology), V5-Tag (1:1000, D3H8Q, Cell Signaling Technology), HA (1:1000, C29F4, Cell Signaling Technology), human eIF2D (1:2000, ab108218, Abcam), mouse eIF2D (1:1500, 12840-1-AP, Proteintech), p-eIF2α (1:1000, 119A11, Cell Signaling Technology), eIF2α (1:1000, L57A5, Cell Signaling Technology), α-tubulin (1:5000, YL1/2, Abcam), or β-actin (1:5000, A5441, Sigma). Following washing, the membrane was incubated for 1 h at room temperature with anti-mouse (1:5000, GE Healthcare), anti-rabbit (1:5000, GE Healthcare), or anti-rat horseradish peroxidase–conjugated secondary antibodies (1:1000, Cell Signaling Technology). The signal was detected using SuperSignal West Dura Extended Duration Substrate (ThermoFisher Scientific) and analyzed using ChemiDoc MP Imaging System and Image Lab software (version 6.0.1, BIO-RAD). Full scan western blot images are provided in the Source Data file.

Luciferase assay

The cells were lysed with 1× passive lysis buffer (Promega). Levels of nLuc and fLuc were assessed using Nano-Glo Dual-Luciferase Reporter assay system (Promega) and a Wallac 1420 VICTOR 3V luminometer (Perkin Elmer) according to the manufacturer’s protocol. The 2030 Workstation software (version 4.0) was used.

RT-PCR

To analyze the expression levels of C. elegans mRNA, total RNA was extracted using TRIzol (ThermoFisher Scientific) according to the manufacturer’s protocol and treated with TURBO DNase (ThermoFisher Scientific) for 30 min at 37 °C. RNA was then isolated using RNeasy Mini kit (Qiagen). cDNA was generated using SuperScript IV First-Strand Synthesis System (ThermoFisher Scientific). Quantitative RT-PCR was performed using Power SYBR Green PCR Master Mix (ThermoFisher Scientific) and primer sets (Supplementary Data 2) in a CFX96 Real-Time System (Bio-Rad). The CFX Manager software (version 3.1) was used.

To analyze mRNA expression levels in iPSC neurons, total RNA was extracted from siRNA-treated motor neurons using an RNeasy Mini Kit. The cDNA was generated using iSCRIPT Reverse Transcription Supermix (BIO-RAD). RT-qPCR analysis was performed using the iTaq Universal SYBR Green Supermix (BIO-RAD) on the CFX system. To calculate relative expression, the value of the average cycle of threshold (Ct) for housekeeping genes (GAPDH and ACTIN) was subtracted from the average Ct value of eIF2D. This ΔCt was then used to determine the relative gene expression described by the function ²⁻ΔCt (ΔΔCt), represented as a value relative to the control sample.

ELISA

Two ELISA methods were used and DPRs were detected in a blinded fashion. (A) The worm pellets were suspended in cold co-IP buffer consisting of 50 mM Tris-HCl, pH 7.4, 300 mM NaCl, 5 mM EDTA, 1% Triton-X 100, 2% sodium dodecyl sulfate, 1 × Halt^TM Protease, and Phosphatase Inhibitor Cocktail (ThermoFisher Scientific) and sonicated with 10 cycles of 0.5 s pulse/0.5 s pause. Protein lysates were cleared by centrifugation at 16,000 × g for 20 min at 4 °C. The protein concentration was determined using a BCA protein assay kit (ThermoFisher Scientific). Lysates were diluted to the same concentration using co-IP buffer, and the levels of poly-GP in lysates were measured with a Meso Scale Discovery-based immunoassay as described previously⁷¹. (B) C. elegans, HEK293 cells, and human patient iPSC-derived neurons were homogenized in lysis buffer containing 150 mM NaCl, 25 mM Tris, pH 7.5, 1 mM EDTA, 1 mM EGTA,1% Triton-X 100, 0.5% SDS, and 1 × Halt^TM Protease Inhibitor Cocktail (ThermoFisher Scientific) and sonicated at a 20% pulse rate for 15–20 s on ice. Lysates were centrifuged at 16,000 × g for 15–20 min at 4 °C, and the supernatant was collected in a fresh tube. The protein concentration of the lysates was determined with the BCA protein assay (ThermoFisher Scientific). Lysates were diluted to the same concentration with lysis buffer and tested in duplicate wells using Meso Scale Discovery platform. Measurement of DPRs was carried out using a sandwich immunoassay as described earlier⁷².

Statistical analysis

Statistical analysis was performed by an unpaired t-test, one-way ANOVA with Dunnett’s multiple comparisons test or Tukey’s multiple comparison test, and two-way ANOVA with the Šídák multiple comparison test using GraphPad Prism version 8.2.1. P-values for the worm lifespan assay were calculated by the Mantel–Cox log-rank test using GraphPad Prism 8.2.1. A P-value of <0.05 was considered significant. The data are presented as mean ± standard error of the mean (SEM).

Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

Data availability

The data supporting the findings of this study are available from the corresponding authors upon reasonable request. Source data are provided with this paper.

References

DeJesus-Hernandez, M. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245–256 (2011).
Article CAS PubMed PubMed Central Google Scholar
Renton, A. E. et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257–268 (2011).
Article CAS PubMed PubMed Central Google Scholar
Taylor, J. P., Brown, R. H. Jr. & Cleveland, D. W. Decoding ALS: from genes to mechanism. Nature 539, 197–206 (2016).
Article ADS PubMed PubMed Central Google Scholar
Nguyen, L., Cleary, J. D. & Ranum, L. P. W. Repeat-associated non-ATG translation: molecular mechanisms and contribution to neurological disease. Annu. Rev. Neurosci. 42, 227–247 (2019).
Article CAS PubMed PubMed Central Google Scholar
Freibaum, B. D. & Taylor, J. P. The role of dipeptide repeats in C9ORF72-related ALS-FTD. Front Mol. Neurosci. 10, 35 (2017).
Article PubMed PubMed Central CAS Google Scholar
Mori, K. et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 339, 1335–1338 (2013).
Article ADS CAS PubMed Google Scholar
Zu, T. et al. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl Acad. Sci. USA 110, E4968–4977 (2013).
Article CAS PubMed PubMed Central Google Scholar
Gendron, T. F. et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 126, 829–844 (2013).
Article CAS PubMed PubMed Central Google Scholar
Mann, D. M. et al. Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. Acta Neuropathol. Commun. 1, 68 (2013).
Article PubMed PubMed Central Google Scholar
Mackenzie, I. R. et al. Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol. 130, 845–861 (2015).
Article CAS PubMed Google Scholar
Fuchs, G. et al. Kinetic pathway of 40S ribosomal subunit recruitment to hepatitis C virus internal ribosome entry site. Proc. Natl Acad. Sci. USA 112, 319–325 (2015).
Article ADS CAS PubMed Google Scholar
Olivares, E. et al. The 5’ untranslated region of the human T-cell lymphotropic virus type 1 mRNA enables cap-independent translation initiation. J. Virol. 88, 5936–5955 (2014).
Article PubMed PubMed Central Google Scholar
Yamada, S. B. et al. RPS25 is required for efficient RAN translation of C9orf72 and other neurodegenerative disease-associated nucleotide repeats. Nat. Neurosci. 22, 1383–1388 (2019).
Article CAS PubMed PubMed Central Google Scholar
Zhou, M. et al. Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3. Proc. Natl Acad. Sci. USA 105, 18139–18144 (2008).
Article ADS CAS PubMed PubMed Central Google Scholar
Ayhan, F. et al. SCA8 RAN polySer protein preferentially accumulates in white matter regions and is regulated by eIF3F. EMBO J. 37, e99023 (2018).
Article PubMed PubMed Central CAS Google Scholar
Goodman, L. D. et al. eIF4B and eIF4H mediate GR production from expanded G4C2 in a Drosophila model for C9orf72-associated ALS. Acta Neuropathol. Commun. 7, 62 (2019).
Article PubMed PubMed Central Google Scholar
Kim, J. H., Park, S. M., Park, J. H., Keum, S. J. & Jang, S. K. eIF2A mediates translation of hepatitis C viral mRNA under stress conditions. EMBO J. 30, 2454–2464 (2011).
Article CAS PubMed PubMed Central Google Scholar
Starck, S. R. et al. Translation from the 5’ untranslated region shapes the integrated stress response. Science 351, aad3867 (2016).
Article PubMed PubMed Central CAS Google Scholar
Sendoel, A. et al. Translation from unconventional 5’ start sites drives tumour initiation. Nature 541, 494–499 (2017).
Article ADS CAS PubMed PubMed Central Google Scholar
Sonobe, Y. et al. Translation of dipeptide repeat proteins from the C9ORF72 expanded repeat is associated with cellular stress. Neurobiol. Dis. 116, 155–165 (2018).
Article CAS PubMed PubMed Central Google Scholar
Cheng, W. et al. CRISPR-Cas9 screens identify the RNA helicase DDX3X as a repressor of C9ORF72 (GGGGCC)n repeat-associated non-AUG translation. Neuron 104, 885–898 (2019).
Article CAS PubMed PubMed Central Google Scholar
Kramer, N. J. et al. Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts. Science 353, 708–712 (2016).
Article ADS CAS PubMed PubMed Central Google Scholar
Therrien, M., Rouleau, G. A., Dion, P. A. & Parker, J. A. Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. PLoS ONE 8, e83450 (2013).
Article ADS PubMed PubMed Central CAS Google Scholar
Ji, Y. J. et al. C9orf72/ALFA-1 controls TFEB/HLH-30-dependent metabolism through dynamic regulation of Rag GTPases. PLoS Genet. 16, e1008738 (2020).
Article CAS PubMed PubMed Central Google Scholar
Corrionero, A. & Horvitz, H. R. A C9orf72 ALS/FTD ortholog acts in endolysosomal degradation and lysosomal homeostasis. Curr. Biol. 28, 1522–1535.e1525 (2018).
Article CAS PubMed Google Scholar
Stefanakis, N., Carrera, I. & Hobert, O. Regulatory logic of pan-neuronal gene expression in C. elegans. Neuron 87, 733–750 (2015).
Article CAS PubMed PubMed Central Google Scholar
Guo, Q. et al. In situ structure of neuronal C9orf72 poly-GA aggregates reveals proteasome recruitment. Cell 172, 696–705 (2018).
Article CAS PubMed PubMed Central Google Scholar
Chang, Y. J., Jeng, U. S., Chiang, Y. L., Hwang, I. S. & Chen, Y. R. The glycine-alanine dipeptide repeat from C9orf72 hexanucleotide expansions forms toxic amyloids possessing cell-to-cell transmission properties. J. Biol. Chem. 291, 4903–4911 (2016).
Article CAS PubMed PubMed Central Google Scholar
Green, K. M. et al. RAN translation at C9orf72-associated repeat expansions is selectively enhanced by the integrated stress response. Nat. Commun. 8, 2005 (2017).
Article ADS PubMed PubMed Central CAS Google Scholar
Tabet, R. et al. CUG initiation and frameshifting enable production of dipeptide repeat proteins from ALS/FTD C9ORF72 transcripts. Nat. Commun. 9, 152 (2018).
Article ADS PubMed PubMed Central CAS Google Scholar
Boivin, M. et al. Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. EMBO J. 39, e100574 (2020).
Article CAS PubMed PubMed Central Google Scholar
Chew, J. et al. Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science 348, 1151–1154 (2015).
Article ADS CAS PubMed PubMed Central Google Scholar
Liu, Y. et al. C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron 90, 521–534 (2016).
Article CAS PubMed Google Scholar
Choi, S. Y. et al. C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat. Neurosci. 22, 851–862 (2019).
Article CAS PubMed PubMed Central Google Scholar
Almeida, S. et al. Production of poly(GA) in C9ORF72 patient motor neurons derived from induced pluripotent stem cells. Acta Neuropathol. 138, 1099–1101 (2019).
Article PubMed PubMed Central Google Scholar
Javer, A., Ripoll-Sánchez, L. & Brown, A. E. X. Powerful and interpretable behavioural features for quantitative phenotyping of Caenorhabditis elegans. Philos. Trans. R. Soc. Lond. B Biol. Sci. 373, 20170375 (2018).
Article PubMed PubMed Central Google Scholar
Yemini, E., Jucikas, T., Grundy, L. J., Brown, A. E. & Schafer, W. R. A database of Caenorhabditis elegans behavioral phenotypes. Nat. Methods 10, 877–879 (2013).
Article CAS PubMed PubMed Central Google Scholar
Dmitriev, S. E. et al. GTP-independent tRNA delivery to the ribosomal P-site by a novel eukaryotic translation factor. J. Biol. Chem. 285, 26779–26787 (2010).
Article CAS PubMed PubMed Central Google Scholar
Kearse, M. G. & Wilusz, J. E. Non-AUG translation: a new start for protein synthesis in eukaryotes. Genes Dev. 31, 1717–1731 (2017).
Article CAS PubMed PubMed Central Google Scholar
Yoon, H. J. & Donahue, T. F. The suil suppressor locus in Saccharomyces cerevisiae encodes a translation factor that functions during tRNA(iMet) recognition of the start codon. Mol. Cell Biol. 12, 248–260 (1992).
CAS PubMed PubMed Central Google Scholar
Lomakin, I. B., Shirokikh, N. E., Yusupov, M. M., Hellen, C. U. & Pestova, T. V. The fidelity of translation initiation: reciprocal activities of eIF1, IF3 and YciH. EMBO J. 25, 196–210 (2006).
Article CAS PubMed Google Scholar
Cheng, W. et al. C9ORF72 GGGGCC repeat-associated non-AUG translation is upregulated by stress through eIF2alpha phosphorylation. Nat. Commun. 9, 51 (2018).
Article ADS PubMed PubMed Central CAS Google Scholar
May, S. et al. C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathol. 128, 485–503 (2014).
Article CAS PubMed PubMed Central Google Scholar
Zhang, Y. J. et al. Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol. 128, 505–524 (2014).
Article CAS PubMed PubMed Central Google Scholar
Zhang, Y. J. et al. C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat. Neurosci. 19, 668–677 (2016).
Article CAS PubMed PubMed Central Google Scholar
Schludi, M. H. et al. Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss. Acta Neuropathol. 134, 241–254 (2017).
Article CAS PubMed PubMed Central Google Scholar
Khosravi, B. et al. Cell-to-cell transmission of C9orf72 poly-(Gly-Ala) triggers key features of ALS/FTD. EMBO J. 39, e102811 (2020).
Article CAS PubMed PubMed Central Google Scholar
Nguyen, L. et al. Antibody therapy targeting RAN proteins rescues C9 ALS/FTD phenotypes in C9orf72 mouse model. Neuron 105, 645–662 (2020).
Article CAS PubMed Google Scholar
Swinnen, B. et al. A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathol. 135, 427–443 (2018).
Article CAS PubMed Google Scholar
Rudich, P. et al. Nuclear localized C9orf72-associated arginine-containing dipeptides exhibit age-dependent toxicity in C. elegans. Hum. Mol. Genet. 26, 4916–4928 (2017).
Article CAS PubMed PubMed Central Google Scholar
Swinnen, B., Robberecht, W. & Van Den Bosch, L. RNA toxicity in non-coding repeat expansion disorders. EMBO J. 39, e101112 (2020).
Article CAS PubMed Google Scholar
Skabkin, M. A. et al. Activities of Ligatin and MCT-1/DENR in eukaryotic translation initiation and ribosomal recycling. Genes Dev. 24, 1787–1801 (2010).
Article CAS PubMed PubMed Central Google Scholar
Hussain, T. et al. Structural changes enable start codon recognition by the eukaryotic translation initiation complex. Cell 159, 597–607 (2014).
Article CAS PubMed PubMed Central Google Scholar
Thakur, A. & Hinnebusch, A. G. eIF1 Loop 2 interactions with Met-tRNA(i) control the accuracy of start codon selection by the scanning preinitiation complex. Proc. Natl Acad. Sci. USA 115, E4159–E4168 (2018).
Article CAS PubMed PubMed Central Google Scholar
Skabkin, M. A., Skabkina, O. V., Hellen, C. U. & Pestova, T. V. Reinitiation and other unconventional posttermination events during eukaryotic translation. Mol. Cell 51, 249–264 (2013).
Article CAS PubMed PubMed Central Google Scholar
Young, D. J. et al. Tma64/eIF2D, Tma20/MCT-1, and Tma22/DENR recycle post-termination 40S subunits in vivo. Mol. Cell 71, 761–774 (2018).
Article CAS PubMed PubMed Central Google Scholar
Zinoviev, A., Hellen, C. U. T. & Pestova, T. V. Multiple mechanisms of reinitiation on bicistronic calicivirus mRNAs. Mol. Cell 57, 1059–1073 (2015).
Article CAS PubMed PubMed Central Google Scholar
Vasudevan, D. et al. Translational induction of ATF4 during integrated stress response requires noncanonical initiation factors eIF2D and DENR. Nat. Commun. 11, 4677 (2020).
Article ADS CAS PubMed PubMed Central Google Scholar
Tusi, S. K. et al. The alternative initiation factor eIF2A plays key role in RAN translation of myotonic dystrophy type 2 CCUG•CAGG repeats. Hum. Mol. Genet. 30, 1020–1029 (2021).
Article PubMed Google Scholar
Kwon, O. S. et al. An mRNA-specific tRNAi carrier eIF2A plays a pivotal role in cell proliferation under stress conditions: stress-resistant translation of c-Src mRNA is mediated by eIF2A. Nucleic Acids Res. 45, 296–310 (2017).
Article CAS PubMed Google Scholar
Brenner, S. The genetics of Caenorhabditis elegans. Genetics 77, 71–94 (1974).
Article CAS PubMed PubMed Central Google Scholar
Hendi, A. & Mizumoto, K. GFPnovo2, a brighter GFP variant for in vivo labeling in C. elegans. MicroPubl. Biol. 2018, https://doi.org/10.17912/49YB-7K39 (2018).
Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 (2012).
Article CAS PubMed PubMed Central Google Scholar
Gendrel, M., Rapti, G., Richmond, J. E. & Bessereau, J. L. A secreted complement-control-related protein ensures acetylcholine receptor clustering. Nature 461, 992–996 (2009).
Article ADS CAS PubMed Google Scholar
Raj, A., van den Bogaard, P., Rifkin, S. A., van Oudenaarden, A. & Tyagi, S. Imaging individual mRNA molecules using multiple singly labeled probes. Nat. Methods 5, 877–879 (2008).
Article CAS PubMed PubMed Central Google Scholar
Ghadge, G. D. et al. Knockdown of GADD34 in neonatal mutant SOD1 mice ameliorates ALS. Neurobiol. Dis. 136, 104702 (2020).
Article CAS PubMed Google Scholar
Cashman, N. R. et al. Neuroblastoma × spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 194, 209–221 (1992).
Article CAS PubMed Google Scholar
Ortega, J. A. et al. Nucleocytoplasmic proteomic analysis uncovers eRF1 and nonsense-mediated decay as modifiers of ALS/FTD C9orf72 toxicity. Neuron 106, 90–107 (2020).
Article CAS PubMed PubMed Central Google Scholar
Boulting, G. L. et al. A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 29, 279–286 (2011).
Article CAS PubMed PubMed Central Google Scholar
Shi, Y. et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 24, 313–325 (2018).
Article CAS PubMed PubMed Central Google Scholar
Andrade, N. S. et al. Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD. Mol. Neurodegener. 15, 13 (2020).
Article CAS PubMed PubMed Central Google Scholar
Krishnan, G. et al. CRISPR deletion of the C9ORF72 promoter in ALS/FTD patient motor neurons abolishes production of dipeptide repeat proteins and rescues neurodegeneration. Acta Neuropathol. 140, 81–84 (2020).
Article CAS PubMed PubMed Central Google Scholar

Download references

Acknowledgements

We thank the Caenorhabditis Genetics Center (CGC), which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440), for providing strains. The antibodies in the MSD assay that detect poly-GA in human iPSC-derived motor neurons were used at Biogen, and were discovered by Neurimmune AG. This work was supported by a grant from the Lohengrin Foundation (R.P.R., P.K.), a basic science pilot grant from the Association for Frontotemporal Degeneration (AFTD) (R.P.R., P.K.), NIH NINDS/NIA grant R01NS104219 (E.K.), NIH grant R37NS057553 (F.-B.G.), NIH grant R01NS101986 (F.-B.G.), and the Target ALS Foundation (F.-B.G.). E.K. is a Les Turner ALS Research Center Investigator and a New York Stem Cell Foundation – Robertson Investigator.

Author information

These authors contributed equally: Raymond P. Roos, Paschalis Kratsios.

Authors and Affiliations

University of Chicago Medical Center, 5841S. Maryland Avenue, Chicago, IL, 60637, USA
Yoshifumi Sonobe, Jihad Aburas, Ghanashyam Ghadge, Raymond P. Roos & Paschalis Kratsios
Department of Neurology, University of Chicago Medical Center, 5841S. Maryland Avenue, Chicago, IL, 60637, USA
Yoshifumi Sonobe, Ghanashyam Ghadge & Raymond P. Roos
The Grossman Institute for Neuroscience, Quantitative Biology, and Human Behavior, University of Chicago, Chicago, IL, USA
Yoshifumi Sonobe, Jihad Aburas, Ghanashyam Ghadge, Raymond P. Roos & Paschalis Kratsios
Department of Neurobiology, University of Chicago, Chicago, IL, USA
Jihad Aburas & Paschalis Kratsios
Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 01605, USA
Gopinath Krishnan & Fen-Biao Gao
The Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, USA
Andrew C. Fleming & Evangelos Kiskinis
MRC London Institute of Medical Sciences, London, UK
Priota Islam, Eleanor C. Warren & André E. X. Brown
Institute of Clinical Sciences, Imperial College London, London, UK
Priota Islam, Eleanor C. Warren & André E. X. Brown
Neuromuscular & Movement Disorders, Biogen, Cambridge, MA, 02142, USA
Yuanzheng Gu & Mark W. Kankel
Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
Tania F. Gendron

Authors

Yoshifumi Sonobe
View author publications
You can also search for this author in PubMed Google Scholar
Jihad Aburas
View author publications
You can also search for this author in PubMed Google Scholar
Gopinath Krishnan
View author publications
You can also search for this author in PubMed Google Scholar
Andrew C. Fleming
View author publications
You can also search for this author in PubMed Google Scholar
Ghanashyam Ghadge
View author publications
You can also search for this author in PubMed Google Scholar
Priota Islam
View author publications
You can also search for this author in PubMed Google Scholar
Eleanor C. Warren
View author publications
You can also search for this author in PubMed Google Scholar
Yuanzheng Gu
View author publications
You can also search for this author in PubMed Google Scholar
Mark W. Kankel
View author publications
You can also search for this author in PubMed Google Scholar
André E. X. Brown
View author publications
You can also search for this author in PubMed Google Scholar
Evangelos Kiskinis
View author publications
You can also search for this author in PubMed Google Scholar
Tania F. Gendron
View author publications
You can also search for this author in PubMed Google Scholar
Fen-Biao Gao
View author publications
You can also search for this author in PubMed Google Scholar
Raymond P. Roos
View author publications
You can also search for this author in PubMed Google Scholar
Paschalis Kratsios
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

Study design: Y.S., R.P.R., and P.K. Literature research: Y.S., R.P.R., and P.K. Experimental studies: Y.S., J.A., G.K., A.C.F, G.G., P.I., E.C.W., Y.G., M.W.K., T.F.G., E.K., and P.K. Data analysis/interpretation: Y.S., J.A., A.E.X.B., P.K., R.P.R. A.C.F., E.K, T.F.G., F.-B.G., R.P.R., and P.K. Statistical analysis: Y.S. and A.E.X.B. Manuscript preparation—original draft: Y.S., R.P.R., and P.K. Manuscript editing: Y.S., G.G., A.C.F, E.K., T.F.G., R.P.R., and P.K.

Corresponding authors

Correspondence to Raymond P. Roos or Paschalis Kratsios.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Peer review information Nature Communications thanks the anonymous reviewers for their contributions to the peer review of this work. Peer review reports are available.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Peer Review File

Supplementary Data 1

Supplementary Data 2

Supplementary Data 3

Supplementary Movie 1

Supplementary Movie 2

Supplementary Movie 3

Description of additional supplementary files

Reporting Summary

Source data

Source Data File

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

Sonobe, Y., Aburas, J., Krishnan, G. et al. A C. elegans model of C9orf72-associated ALS/FTD uncovers a conserved role for eIF2D in RAN translation. Nat Commun 12, 6025 (2021). https://doi.org/10.1038/s41467-021-26303-x

Download citation

Received: 06 June 2020
Accepted: 28 September 2021
Published: 15 October 2021
DOI: https://doi.org/10.1038/s41467-021-26303-x

This article is cited by

Translation dysregulation in neurodegenerative diseases: a focus on ALS
- Shaopeng Wang
- Shuying Sun
Molecular Neurodegeneration (2023)
Single-molecule imaging reveals distinct elongation and frameshifting dynamics between frames of expanded RNA repeats in C9ORF72-ALS/FTD
- Malgorzata J. Latallo
- Shaopeng Wang
- Bin Wu
Nature Communications (2023)
Reconstitution of C9orf72 GGGGCC repeat-associated non-AUG translation with purified human translation factors
- Hayato Ito
- Kodai Machida
- Hideki Taguchi
Scientific Reports (2023)
Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD
- Gopinath Krishnan
- Denitza Raitcheva
- Fen-Biao Gao
Nature Communications (2022)

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.